Scientists have identified a newly defined condition linked to a common genetic cause of severe epilepsy in children. The condition, termed RNU2-2-related neurodevelopmental disorder, manifests as seizures and significant developmental delays typically before a child reaches one year of age.
Understanding the Discovery
Researchers at the University of Manchester and Manchester University NHS Foundation Trust analyzed changes in hundreds of RNU genes using data from the 100,000 Genomes Project. This analysis led to the identification of 84 individuals, including five-year-old Ava Begley from Sydney, Australia, diagnosed with the condition. Many more cases are believed to be currently undiagnosed globally.
Ava, who is non-verbal and experiences complex neurological symptoms, previously suffered as many as 100 to 200 seizures daily, now better controlled with medication. Her parents expressed relief at receiving a diagnosis, stating it provides “a name and a place in the medical world” and offers hope for future treatments.
The Genetic Component
The research, published in the journal Nature Genetics, reveals that as many as one in 100 people could unknowingly carry the gene responsible for this disorder. If both parents are carriers, there is a one in four chance with each pregnancy that their child will be affected. Approximately one in 40,000 people are estimated to be living with this condition, making it one of the more prevalent known neurodevelopmental disorders.
Study lead Adam Jackson, from the Manchester Centre for Genomic Medicine, noted the surprising impact of changes in this “tiny gene.”
What’s Next?
Further research could focus on understanding the precise mechanisms by which variations in the RNU2-2 gene lead to neurodevelopmental issues. Scientists may explore gene therapy or other interventions to address the underlying genetic cause. Increased awareness of the condition could lead to earlier diagnosis and improved management of symptoms. It is also likely that ongoing genetic studies will identify additional cases and refine estimates of prevalence.
Frequently Asked Questions
What are the symptoms of RNU2-2-related neurodevelopmental disorder?
The disorder is characterized by intellectual disability, autistic behavior, microcephaly, hypotonia, epilepsy, and hyperventilation.
How was this condition discovered?
Researchers from the University of Manchester and Manchester University NHS Foundation Trust analyzed changes in several hundred RNU genes in people involved in the 100,000 Genomes Project.
Is there a risk of passing this condition on to future children?
If both parents are carriers of the faulty gene, there is a one in four chance with every pregnancy that their child could be affected.
What role might increased genetic research play in understanding and addressing rare neurological conditions?
